Brain cancer trial aims to stop deadly clots with common blood thinner
NCT ID NCT05683808
First seen Jan 31, 2026 · Last updated May 14, 2026 · Updated 15 times
Summary
This study tests whether the blood thinner apixaban can safely prevent blood clots in people with newly diagnosed grade 4 glioma (a type of brain cancer). About 40 participants will take apixaban while receiving standard radiation and chemotherapy. The main goal is to check for bleeding risks and see if the drug reduces clot formation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Vermont Medical Center
RECRUITINGBurlington, Vermont, 05401, United States
Conditions
Explore the condition pages connected to this study.